Large-Scale Multi-omic Analysis of COVID-19 Severity
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2020.07.17.20156513: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Raw files were searched using MaxQuant quantitative software package (Cox et al., 2014) MaxQuantsuggested: (MaxQuant, RRID:SCR_014485)Identification and quantification of targeted peptides were performed using Skyline open access software package (version 20.1). Skylinesuggested: (Skyline, RRID:SCR_014080)For the Englert results, fastq files were downloaded from the Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/), accession GSE84439, samples/ runs SRR3923733-SRR3923739 (omitting SRR3923734) and SRR3923747-SRR3923753. Gene Expression Omnibussuggested: (Gene Expression …SciScore for 10.1101/2020.07.17.20156513: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Raw files were searched using MaxQuant quantitative software package (Cox et al., 2014) MaxQuantsuggested: (MaxQuant, RRID:SCR_014485)Identification and quantification of targeted peptides were performed using Skyline open access software package (version 20.1). Skylinesuggested: (Skyline, RRID:SCR_014080)For the Englert results, fastq files were downloaded from the Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/), accession GSE84439, samples/ runs SRR3923733-SRR3923739 (omitting SRR3923734) and SRR3923747-SRR3923753. Gene Expression Omnibussuggested: (Gene Expression Omnibus (GEO, RRID:SCR_005012)Only mRNA (accessions NM_xxxx and XM_xxxx) and rRNA (excluding 5.8S) was then extracted, and immunoglobulin transcripts were downloaded from ENSEMBL (IG_C, IG_D, IG_J and IG_V). ENSEMBLsuggested: (Ensembl, RRID:SCR_002344)RNA-Seq expression estimation was performed by RSEM v 1.3.0 (parameters: seed-length=20, no-qualities, bowtie2-k=200, bowtie2-sensitivity-level=sensitive) (Li and Dewey, 2011), with bowtie-2 (v 2.3.4.1) for the alignment step (Langmead and Salzberg, 2012), using a custom hg38 reference. RSEMsuggested: (RSEM, RRID:SCR_013027)We examined all differentially expressed genes associated with an FDR value less than 0.01 and fold-change greater than two as determined by EBSeq (Englert et al., 2019b; Leng et al., 2013). EBSeqsuggested: (EBSeq, RRID:SCR_003526)We considered all gene sets associated with Gene Ontology terms (Ashburner et al., 2000), gene sets in the Hallmark collection (Liberzon et al., 2015), and gene sets in the Canonical Pathway collection in the MSigDB repository (Liberzon et al., 2011), which includes pathways from KEGG (Kanehisa and Goto, 2000) and Reactome (Joshi-Tope et al., 2005). KEGGsuggested: (KEGG, RRID:SCR_012773)Creation of covid-omics.app: The webtool was developed in Python (3.7.4) using the Plotly Dash package (1.12.0) and the source code is accessible via GitHub (https://github.com/ijmiller2/COVID-19_Multi-Omics/), under the src/dash directory. Plotlysuggested: (Plotly, RRID:SCR_013991)The R2 and p-value metrics displayed on the linear regression page are calculated using the statsmodels (0.11.1) library in Python. Pythonsuggested: (IPython, RRID:SCR_001658)ExtraTrees classification of severe and non-severe cases: Molecular measurements of metabolites, lipids, proteins, and transcripts were read into Python from the SQLite database. SQLitesuggested: (SQLite, RRID:SCR_017672)All metrics were computed with the standard functions in scikit-learn, and the reported feature importances are the Gini type. scikit-learnsuggested: (scikit-learn, RRID:SCR_002577)RSEM expression estimates for Englert samples can be downloaded from the MassIVE database. MassIVEsuggested: NoneResults from OddPub: Thank you for sharing your code and data.
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:All large-scale omics studies have limitations but, ideally, still stimulate the generation of numerous testable hypotheses. This work is no exception; and, in a very real sense, it represents a starting point in the response to the urgent need to wholly define this devastating disease. Future work should include a larger and broader patient population. The samples derived here came from a single center, and although our population is racially diverse, it does not necessarily replicate factors related to geography or population socioeconomic status, among others. Another limitation was that the control group was generated by blindly enrolling patients presenting with COVID-19-compatible symptoms. While this approach provided an important reference, the non-COVID-19 patients admitted to the ICU, not all of these patients presented with the same criteria of ARDS. We recognize this approach is not ideal and expect that future studies with prospective enrollment of patients fully matching the present COVID-19 clinical features will provide a better reference to the current cohort. The practicalities associated with study design and implementation during a pandemic presented another possible limitation. For example, while we enrolled the patients at the time of hospital admission, we could not control the period that elapsed between the disease development and the blood sampling. Nevertheless, previous research on the genomic landscape of patients with sepsis indicates the timing ...
Results from TrialIdentifier: We found the following clinical trial numbers in your paper:
Identifier Status Title NCT03466073 Completed A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rh… NCT04358406 Recruiting Rhu-pGSN for Severe Covid-19 Pneumonia NCT04324021 Terminated Efficacy and Safety of Emapalumab and Anakinra in Reducing H… NCT04326790 Recruiting The GReek Study in the Effects of Colchicine in Covid-19 cOm… Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
